台股 » 個股 » 智擎 » 籌碼相關 » 融資融券與借券

智擎

(4162)
可現股當沖
  • 股價
    90.7
  • 漲跌
    ▲0.5
  • 漲幅
    +0.55%
  • 成交量
    231
  • 產業
    上櫃 生技醫療類股
  • 304人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
智擎 (4162) 融資融券與借券

股票投資新手教室: 一分鐘搞懂「融資融券」

智擎 (4162) 融資融券與借券

智擎 (4162) 近三十日融資融券與借券賣出
日期 融資 融券 資券互抵(張) 資券當沖(%) 券資比(%) 價格 比例 成交量
增加 餘額 使用率% 增加 餘額 使用率%
04/2447,66221.04030.01000.0490.70.55%231
04/23-637,65821.03030.01000.0490.22.50%372
04/22-557,72121.2030.0110.180.0488-1.12%548
04/1927,77621.35030.0120.210.0489-4.91%954
04/18117,77421.35030.01000.0493.61.08%236
04/17-197,76321.32-2030.01000.0492.61.76%556
04/162457,78221.3717230.06000.391-3.29%1,161
04/15307,53720.7260.02000.0894.1-3.09%1,076
04/12-17,50720.61140.01000.0597.1-0.82%559
04/11-37,50820.62-230.01000.0497.9-0.91%446
04/10-157,51120.62050.01000.0798.81.23%536
04/09-217,52620.67-150.0110.160.0797.6-1.51%642
04/0837,54720.72-160.02000.0899.10.10%549
04/03127,54420.71270.02000.09990.10%662
04/0227,53220.68-450.01000.0798.9-0.70%436
04/011017,53020.68390.02000.1299.60.40%661
03/29-217,42920.4-160.0240.720.0899.2-0.20%552
03/28-807,45020.46-370.02000.0999.4-0.30%1,221
03/272097,53020.686100.0310.060.1399.73.00%1,605
03/26-1317,32120.1-1140.01000.0596.8-4.16%1,442
03/251797,45220.4612150.04170.750.21014.66%2,269
03/22147,27319.97330.0161.220.0496.50.52%491
03/21567,25919.93000000960.21%406
03/20777,20319.7800000095.8-1.03%1,099
03/191807,12619.57-30000096.83.75%1,208
03/18156,94619.07-1430.01000.0493.30.11%297
03/15-246,93119.03-4170.05000.2593.20.54%412
03/14-186,95519.1-7210.0610.220.392.70.32%455
03/13-696,97319.15-2280.08000.492.4-3.35%1,343
03/12-27,04219.34-2300.08000.4395.60.53%482
日期 融券 借券賣出 價格 比例 成交量
買進 賣出 增加 餘額 使用率% 賣出 還券 調整 增加 餘額
04/2400003@Limit20.0120470-275,58190.70.55%231
04/2300003@Limit20.01149055,60890.22.50%372
04/2200003@Limit20.0171810-105,60388-1.12%548
04/1911003@Limit20.011701840-145,61389-4.91%954
04/1800003@Limit20.0119450-265,62793.61.08%236
04/172110-203@Limit20.0151300-1255,65392.61.76%556
04/1611801723@Limit20.06104650395,77891-3.29%1,161
04/1513026@Limit20.021754001355,73994.1-3.09%1,076
04/1201014@Limit20.01671050-385,60497.1-0.82%559
04/11200-23@Limit20.0145740-295,64297.9-0.91%446
04/1000005@Limit20.0116760-605,67198.81.23%536
04/09100-15@Limit20.014444005,73197.6-1.51%642
04/08100-16@Limit20.0235760-415,73199.10.10%549
04/0313027@Limit20.02521790-1275,772990.10%662
04/02400-45@Limit20.01481050-575,89998.9-0.70%436
04/0103039@Limit20.02361120-765,95699.60.40%661
03/29100-16@Limit20.02522050-1536,03299.2-0.20%552
03/28410-37@Limit20.026690-636,18599.4-0.30%1,221
03/27060610@Limit20.031583040-1466,24899.73.00%1,605
03/261320-114@Limit20.018800886,39496.8-4.16%1,442
03/2501201215@Limit20.0430036,3061014.66%2,269
03/2203033@Limit20.0117900-736,30396.50.52%491
03/2100000@Limit202480166,376960.21%406
03/2000000@Limit20130790516,36095.8-1.03%1,099
03/19003-30@Limit20104001046,30996.83.75%1,208
03/18707-143@Limit20.012400246,20593.30.11%297
03/15510-417@Limit20.0540046,18193.20.54%412
03/14810-721@Limit20.0612180-66,17792.70.32%455
03/1316140-228@Limit20.08107001076,18392.4-3.35%1,343
03/12310-230@Limit20.0822110116,07695.60.53%482
日期 當沖成交張數 買進成交金額 賣出成交金額 現股當沖率(%) 平均盈虧
04/24585,264,7005,265,30025.1110.34
04/23706,280,3006,294,70018.82205.71
04/2216114,285,30014,300,60029.3895.03
04/1919717,677,00017,715,40020.65194.92
04/18494,549,3004,571,50020.76453.06
04/1715114,017,50014,072,60027.16364.9
04/1620919,223,10019,270,80018228.23
04/1519218,202,90018,224,40017.84111.98
04/1211711,399,50011,394,40020.93-43.59
04/1111911,689,00011,693,90026.6841.18
04/1011010,884,30010,887,40020.5228.18
04/0912512,313,20012,268,50019.47-357.6
04/0822222,146,10022,151,70040.4425.23
04/0328327,817,80027,957,10042.75492.23
04/02898,848,2008,839,60020.41-96.63
04/0115315,316,80015,304,30023.15-81.7
03/2914214,091,50014,103,20025.7282.39
03/2854654,690,80054,714,50044.7243.41
03/2757156,646,40056,854,10035.58363.75
03/2636535,850,80035,940,40025.31245.48
03/2555955,721,20056,042,20024.64574.24
03/22938,952,5008,960,70018.9488.17
03/21373,541,4003,547,0009.11151.35
03/2024723,590,20023,607,60022.4770.45
03/1928827,948,30027,901,40023.84-162.85
03/18706,543,6006,544,30023.5710
03/151059,835,6009,831,80025.49-36.19
03/1414113,123,50013,129,30030.9941.13
03/1328026,287,30026,202,30020.85-303.57
03/121029,781,8009,776,70021.16-50
智擎明、後年新藥將有斬獲 歐洲藥證+一期臨床數據結果Anue鉅亨-2023/11/03
智擎 相關文章